ZOFRAN Side Effects

6630223-2 |
on Mar 05, 2010 Male patient from UNITED STATES , 56 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Zofran (View Usage). . Zofran dosage: 1tab Twice Per Day. During the same period patient was treated with DILAUDID (View Dilaudid Review and Dilaudid Label ), ATIVAN (View Ativan Review and Ativan Label ), PREVACID (View Prevacid Review and Prevacid Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), MEGACE (View Megace Review and Megace Label ).

6621055-X | Accidental Exposure, Agitation, Hyperreflexia, Overdose
Patient was taking Zofran (View Usage). Patient had the following side effects: accidental exposure, agitation, hyperreflexia, overdose on Mar 02, 2010 from UNITED STATES Additional patient health information: Female patient , child 2 years of age, weighting 22.05 lb, . Zofran dosage: 40mg Single Dose. Patient was hospitalized.

6615968-2 |
Adverse event was reported on Feb 26, 2010 by a Female patient taking Zofran (View Usage) (Dosage: ) . Location: UNITED STATES , 55 years of age, . During the same period patient was treated with VALTREX (View Valtrex Review and Valtrex Label ).

6610789-9 | Hepatitis Acute, Multi-organ Failure, Renal Failure, Shock, Transaminases Increased
on Feb 22, 2010 Female patient from GERMANY , 84 years of age, weighting 176.4 lb, was treated with Zofran (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis acute, multi-organ failure, renal failure, shock, transaminases increased. Zofran dosage: 8mg Per Day. During the same period patient was treated with CORDAREX (200mg Per Day) (View Cordarex Review and Cordarex Label ), TAVOR (View Tavor Review and Tavor Label ). Patient was hospitalized.


6602339-8 | Hospice Care, Malignant Neoplasm Progression
on Feb 16, 2010 Female patient from UNITED STATES , 53 years of age, was treated with Zofran (View Usage). Patient had the following side effects: hospice care (What is hospice care?), malignant neoplasm progression. Zofran dosage: . During the same period patient was treated with ZANTAC (View Zantac Review and Zantac Label ).

6600664-8 | Agitation, Completed Suicide, Insomnia
Patient was taking Zofran (View Usage). After Zofran was administered, patient had the following side effects: agitation, completed suicide, insomnia on Feb 23, 2010 from UNITED STATES Additional patient health information: Female patient , 33 years of age, weighting 168.0 lb, was diagnosed with vomiting in pregnancy and. Zofran dosage: 4 Mg Q8 Hrs Po. During the same period patient was treated with VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ).

6594398-6 | Hospice Care, Malignant Neoplasm Progression
Adverse event was reported on Feb 16, 2010 by a Female patient taking Zofran (View Usage) (Dosage: ) . Location: UNITED STATES , 53 years of age, Patient experienced the following unwanted or unexpected effects: hospice care (What is hospice care?), malignant neoplasm progression. During the same period patient was treated with ZANTAC (View Zantac Review and Zantac Label ).

6581628-X | Product Formulation Issue, Product Substitution Issue, Product Taste Abnormal
on Feb 11, 2010 Male patient from UNITED STATES , weighting 250.0 lb, was treated with Zofran (View Usage). Patient had the following side effects: product formulation issue, product substitution issue, product taste abnormal. Zofran dosage: .

6575590-3 | Accidental Exposure, Agitation, Hyperreflexia, Overdose
on Feb 05, 2010 Female patient from UNITED STATES , child 3 years of age, was treated with Zofran (View Usage). After Zofran was administered, patient had the following side effects: accidental exposure, agitation, hyperreflexia, overdose. Zofran dosage: 40mg Single Dose. Patient was hospitalized.

6573600-0 | Circulatory Collapse
Patient was taking Zofran (View Usage). Patient experienced the following unwanted or unexpected effects: circulatory collapse on Feb 04, 2010 from UNITED STATES Additional patient health information: Male patient , 59 years of age, . Zofran dosage: . During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ). Patient was hospitalized.

6570663-3 | Disease Progression, Metastatic Neoplasm, Oedema Peripheral, Pollakiuria
Adverse event was reported on Feb 02, 2010 by a Female patient taking Zofran (View Usage) (Dosage: 8mg Four Times Per Day) was diagnosed with pain (What is pain?) and. Location: BRAZIL , weighting 119.0 lb, Patient had the following side effects: disease progression, metastatic neoplasm, oedema peripheral, pollakiuria. During the same period patient was treated with OMEPRAZOL (1tab Per Day) (View Omeprazol Review and Omeprazol Label ), PARACETAMOL (1tab As Required) (View Paracetamol Review and Paracetamol Label ).

6568451-7 | Agitation, Asthenia, Bladder Catheterisation, Electrocardiogram Change, Extrapyramidal Disorder, Fall, Gait Disturbance, Hip Fracture, Incontinence
on Jan 29, 2010 Female patient from UNITED STATES , 86 years of age, was treated with Zofran (View Usage). After Zofran was administered, patient had the following side effects: agitation, asthenia, bladder catheterisation, electrocardiogram change, extrapyramidal disorder, fall (What is fall?), gait disturbance, hip fracture, incontinence. Zofran dosage: . During the same period patient was treated with TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ), ARICEPT (View Aricept Review and Aricept Label ). Patient was hospitalized and became disabled.

6566844-5 | Acidosis, Cardiac Arrest, Depressed Level Of Consciousness, Hyperthermia, Hyperthermia Malignant, Hypertonia, Muscle Rigidity, Pneumonia, Pyrexia
on Jan 23, 2010 Male patient from SPAIN , child 5 years of age, was diagnosed with vomiting and was treated with Zofran (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, cardiac arrest (What is cardiac arrest?), depressed level of consciousness, hyperthermia, hyperthermia malignant, hypertonia, muscle rigidity, pneumonia (What is pneumonia?), pyrexia. Zofran dosage: 2mg Per Day. During the same period patient was treated with APIRETAL (View Apiretal Review and Apiretal Label ), DALSY (View Dalsy Review and Dalsy Label ), CLARITIN (View Claritin Review and Claritin Label ), CEFTRIAXONA (View Ceftriaxona Review and Ceftriaxona Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), LORATADINE (View Loratadine Review and Loratadine Label ).

6552664-4 | Acidosis, Cardiac Arrest, Depressed Level Of Consciousness, Hyperthermia, Hyperthermia Malignant, Hypertonia, Muscle Rigidity, Pneumonia, Pyrexia
Patient was taking Zofran (View Usage). Patient had the following side effects: acidosis, cardiac arrest (What is cardiac arrest?), depressed level of consciousness, hyperthermia, hyperthermia malignant, hypertonia, muscle rigidity, pneumonia (What is pneumonia?), pyrexia on Jan 23, 2010 from SPAIN Additional patient health information: Male patient , child 5 years of age, was diagnosed with vomiting and. Zofran dosage: 2mg Per Day. During the same period patient was treated with APIRETAL (View Apiretal Review and Apiretal Label ), DALSY (View Dalsy Review and Dalsy Label ), CLARITIN (View Claritin Review and Claritin Label ), CEFTRIAXONA (View Ceftriaxona Review and Ceftriaxona Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), LORATADINE (View Loratadine Review and Loratadine Label ).

6529920-9 | Dyskinesia, Oculogyric Crisis
Adverse event was reported on Dec 29, 2009 by a Female patient taking Zofran (View Usage) (Dosage: 16mg Per Day) was diagnosed with vomiting and. Location: IRELAND , 35 years of age, After Zofran was administered, patient had the following side effects: dyskinesia, oculogyric crisis.

6528461-2 | Dyskinesia, Oculogyric Crisis
on Dec 29, 2009 Female patient from IRELAND , 35 years of age, was diagnosed with vomiting and was treated with Zofran (View Usage). Patient experienced the following unwanted or unexpected effects: dyskinesia, oculogyric crisis. Zofran dosage: 16mg Per Day.

6527150-8 | Hepatic Neoplasm Malignant
on Jan 04, 2010 Male patient from UNITED STATES , 55 years of age, weighting 210.5 lb, was diagnosed with nausea (What is nausea?) and was treated with Zofran (View Usage). Patient had the following side effects: hepatic neoplasm malignant. Zofran dosage: 4mg As Required. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ), NADOLOL (View Nadolol Review and Nadolol Label ), AMBIEN (View Ambien Review and Ambien Label ), ATIVAN (View Ativan Review and Ativan Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ).

6507961-5 | Foetal Growth Retardation, Hypoglycaemia Neonatal, Neonatal Respiratory Distress Syndrome
Patient was taking Zofran (View Usage). After Zofran was administered, patient had the following side effects: foetal growth retardation, hypoglycaemia neonatal, neonatal respiratory distress syndrome on Dec 09, 2009 from SWITZERLAND Additional patient health information: Female patient , weighting 5.29 lb, . Zofran dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ZURCAL (View Zurcal Review and Zurcal Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), FERRO SANOL (1unit Per Day) (View Ferro Sanol Review and Ferro Sanol Label ), ELEVIT (View Elevit Review and Elevit Label ).

6501558-9 | Coma, Intentional Overdose, Loss Of Consciousness, Suicide Attempt, Vomiting
Adverse event was reported on Dec 12, 2009 by a Female patient taking Zofran (View Usage) (Dosage: ) . Location: GERMANY , weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: coma, intentional overdose, loss of consciousness, suicide attempt, vomiting. During the same period patient was treated with PARACETAMOL (500mg See Dosage Text) (View Paracetamol Review and Paracetamol Label ), AMITRIPTYLINE HYDROCHLORIDE (50mg See Dosage Text) (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), WHISKY (1bt See Dosage Text) (View Whisky Review and Whisky Label ). Patient was hospitalized.

6478021-7 | Injection Site Rash, Product Quality Issue, Urticaria
on Nov 30, 2009 Male patient from BULGARIA , 25 years of age, was treated with Zofran (View Usage). Patient had the following side effects: injection site rash, product quality issue, urticaria. Zofran dosage: 8mg Per Day.

6478020-5 | Injection Site Rash, Product Quality Issue, Urticaria
on Nov 30, 2009 Male patient from BULGARIA , 58 years of age, was treated with Zofran (View Usage). After Zofran was administered, patient had the following side effects: injection site rash, product quality issue, urticaria. Zofran dosage: 8mg Per Day.

6478019-9 | Injection Site Rash, Product Quality Issue, Urticaria
Patient was taking Zofran (View Usage). Patient experienced the following unwanted or unexpected effects: injection site rash, product quality issue, urticaria on Nov 30, 2009 from BULGARIA Additional patient health information: Male patient , 53 years of age, . Zofran dosage: 8mg Per Day.

6478018-7 | Injection Site Rash, Product Quality Issue, Urticaria
Adverse event was reported on Nov 30, 2009 by a Female patient taking Zofran (View Usage) (Dosage: 8mg Per Day) . Location: BULGARIA , 48 years of age, Patient had the following side effects: injection site rash, product quality issue, urticaria.

6470788-7 | Coma, Intentional Overdose, Loss Of Consciousness, Suicide Attempt
on Nov 29, 2009 Female patient from GERMANY , weighting 149.9 lb, was treated with Zofran (View Usage). After Zofran was administered, patient had the following side effects: coma, intentional overdose, loss of consciousness, suicide attempt. Zofran dosage: . During the same period patient was treated with PARACETAMOL (500mg See Dosage Text) (View Paracetamol Review and Paracetamol Label ), AMITRIPTYLINE HYDROCHLORIDE (50mg See Dosage Text) (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ). Patient was hospitalized.

6467381-9 | Haemoptysis, Respiratory Arrest
on Nov 24, 2009 Female patient from UNITED STATES , 41 years of age, was treated with Zofran (View Usage). Patient experienced the following unwanted or unexpected effects: haemoptysis, respiratory arrest. Zofran dosage: .

6464844-7 | Anaphylactic Reaction, Feeling Hot, Hyperhidrosis, Loss Of Consciousness, Syncope
Patient was taking Zofran (View Usage). Patient had the following side effects: anaphylactic reaction, feeling hot, hyperhidrosis, loss of consciousness, syncope on Nov 23, 2009 from UNITED STATES Additional patient health information: Male patient , 56 years of age, weighting 242.5 lb, was diagnosed with nausea (What is nausea?), acute lymphocytic leukaemia and. Zofran dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), QUINAPRIL (20mg Per Day) (View Quinapril Review and Quinapril Label ), ALLOPURINOL (300mg Per Day) (View Allopurinol Review and Allopurinol Label ), LIPITOR (10mg Per Day) (View Lipitor Review and Lipitor Label ), DIFLUCAN (200mg Per Day) (View Diflucan Review and Diflucan Label ), VALTREX (500mg Twice Per Day) (View Valtrex Review and Valtrex Label ). Patient was hospitalized.

6437651-9 | Hepatic Neoplasm Malignant
Adverse event was reported on Nov 05, 2009 by a Male patient taking Zofran (View Usage) (Dosage: 4mg As Required) was diagnosed with nausea (What is nausea?) and. Location: UNITED STATES , 55 years of age, After Zofran was administered, patient had the following side effects: hepatic neoplasm malignant. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ), NADOLOL (View Nadolol Review and Nadolol Label ), AMBIEN (View Ambien Review and Ambien Label ), ATIVAN (View Ativan Review and Ativan Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ).

6436304-0 | Diarrhoea, Drooling, Dysphagia, Eating Disorder, Emotional Distress, Hypersensitivity, Lip Swelling, Swollen Tongue
on Nov 05, 2009 Male patient from IRELAND , weighting 65.70 lb, was diagnosed with vomiting, constipation (What is constipation?) and was treated with Zofran (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, drooling, dysphagia, eating disorder (What is eating disorder?), emotional distress, hypersensitivity, lip swelling, swollen tongue. Zofran dosage: 5ml Per Day. During the same period patient was treated with EPILIM (5ml Twice Per Day) (View Epilim Review and Epilim Label ), LOSEC (20mg Twice Per Day) (View Losec Review and Losec Label ), MELATONIN (View Melatonin Review and Melatonin Label ), DUPHALAC (View Duphalac Review and Duphalac Label ), LACTULOSE (20ml Per Day) (View Lactulose Review and Lactulose Label ).

6433464-2 | Dystonia
on Nov 06, 2009 Female patient from UNITED STATES , 55 years of age, was diagnosed with nausea (What is nausea?) and was treated with Zofran (View Usage). Patient had the following side effects: dystonia (What is dystonia?). Zofran dosage: 8mg One Time Iv. During the same period patient was treated with NALBUPHINE (View Nalbuphine Review and Nalbuphine Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), ATIVAN (View Ativan Review and Ativan Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ). Patient was hospitalized.

6432810-3 |
Patient was taking Zofran (View Usage). on Nov 02, 2009 from UNITED STATES Additional patient health information: Female patient , 41 years of age, . Zofran dosage: .

6431469-9 | Pruritus, Rash Erythematous
Adverse event was reported on Nov 05, 2009 by a Female patient taking Zofran (View Usage) (Dosage: X 1 Iv) was diagnosed with pain (What is pain?) and. Location: UNITED STATES , 15 years of age, Patient experienced the following unwanted or unexpected effects: pruritus, rash erythematous. During the same period patient was treated with DILAUDID (X1 Iv) (View Dilaudid Review and Dilaudid Label ).

6425390-X | Normal Tension Glaucoma, Optic Neuritis
on Oct 26, 2009 Male patient from SPAIN , 50 years of age, was diagnosed with hypertension and was treated with Zofran (View Usage). Patient had the following side effects: normal tension glaucoma, optic neuritis. Zofran dosage: 8mg Per Day. During the same period patient was treated with GLEEVEC (400mg Per Day) (View Gleevec Review and Gleevec Label ), LOBIVON (5mg Per Day) (View Lobivon Review and Lobivon Label ), SUTRIL (10mg Per Day) (View Sutril Review and Sutril Label ), BOI K (View Boi-k Review and Boi-k Label ).

6417861-7 | Cardiac Failure
on Oct 23, 2009 Male patient from UNITED STATES , 47 years of age, weighting 144.4 lb, was treated with Zofran (View Usage). After Zofran was administered, patient had the following side effects: cardiac failure. Zofran dosage: .

6413841-6 | Metastatic Malignant Melanoma
Patient was taking Zofran (View Usage). Patient experienced the following unwanted or unexpected effects: metastatic malignant melanoma on Oct 21, 2009 from UNITED STATES Additional patient health information: Female patient , 51 years of age, was diagnosed with prophylaxis of nausea and vomiting and. Zofran dosage: 8mg As Required.

6412235-7 | Polyuria, Proteinuria, Renal Failure Acute
Adverse event was reported on Oct 15, 2009 by a Female patient taking Zofran (View Usage) (Dosage: 4mg Three Times Per Day) . Location: SPAIN , 25 years of age, Patient had the following side effects: polyuria, proteinuria, renal failure acute. During the same period patient was treated with ENANTYUM (View Enantyum Review and Enantyum Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), PERFALGAN (10mgml Three Times Per Day) (View Perfalgan Review and Perfalgan Label ), SYNTOCINON (10iuml Per Day) (View Syntocinon Review and Syntocinon Label ).

6408794-0 | Pyrexia, Vomiting
on Oct 19, 2009 Male patient from UNITED STATES , child 6 years of age, was diagnosed with influenza and was treated with Zofran (View Usage). After Zofran was administered, patient had the following side effects: pyrexia, vomiting. Zofran dosage: . During the same period patient was treated with TAMIFLU (48mg Twice Per Day) (View Tamiflu Review and Tamiflu Label ).

6401945-3 |
on Oct 13, 2009 Female patient from UNITED STATES , 51 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Zofran (View Usage). . Zofran dosage: 8mg As Required. Patient was hospitalized and became disabled.

6388499-5 | Diarrhoea, Drooling, Dysphagia, Eating Disorder, Emotional Distress, Hypersensitivity, Lip Swelling, Swollen Tongue
Patient was taking Zofran (View Usage). Patient had the following side effects: diarrhoea, drooling, dysphagia, eating disorder (What is eating disorder?), emotional distress, hypersensitivity, lip swelling, swollen tongue on Sep 23, 2009 from IRELAND Additional patient health information: Male patient , weighting 65.70 lb, was diagnosed with vomiting, constipation (What is constipation?) and. Zofran dosage: 5ml Per Day. During the same period patient was treated with EPILIM (5ml Twice Per Day) (View Epilim Review and Epilim Label ), LOSEC (20mg Twice Per Day) (View Losec Review and Losec Label ), MELATONIN (View Melatonin Review and Melatonin Label ), DUPHALAC (View Duphalac Review and Duphalac Label ), LACTULOSE (20ml Per Day) (View Lactulose Review and Lactulose Label ).

6386791-1 | Acidosis, Cardiac Arrest, Depressed Level Of Consciousness, Hyperthermia, Hyperthermia Malignant, Muscle Rigidity, Pneumonia, Pyrexia, Serotonin Syndrome
Adverse event was reported on Sep 28, 2009 by a Male patient taking Zofran (View Usage) (Dosage: ) was diagnosed with vomiting and. Location: SPAIN , child 5 years of age, After Zofran was administered, patient had the following side effects: acidosis, cardiac arrest (What is cardiac arrest?), depressed level of consciousness, hyperthermia, hyperthermia malignant, muscle rigidity, pneumonia (What is pneumonia?), pyrexia, serotonin syndrome. During the same period patient was treated with APIRETAL (View Apiretal Review and Apiretal Label ), DALSY (View Dalsy Review and Dalsy Label ), CLARITIN (View Claritin Review and Claritin Label ), CEFTRIAXONA (View Ceftriaxona Review and Ceftriaxona Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), LORATADINE (View Loratadine Review and Loratadine Label ).

6384182-0 | Abdominal Pain Lower, Constipation, Large Intestine Perforation, Nausea
on Sep 24, 2009 Female patient from CANADA , weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with Zofran (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain lower, constipation (What is constipation?), large intestine perforation, nausea (What is nausea?). Zofran dosage: . During the same period patient was treated with CP 751871 (20mgk Every 3 Weeks) (View Cp-751871 Review and Cp-751871 Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), PACLITAXEL (200mgm2 Every 3 Weeks) (View Paclitaxel Review and Paclitaxel Label ), CALCIUM (View Calcium Review and Calcium Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), DEXAMETHASONE 4MG TAB (View Dexamethasone 4mg Tab Review and Dexamethasone 4mg Tab Label ). Patient was hospitalized.

6382596-6 | Neuroleptic Malignant Syndrome
on Sep 24, 2009 Female patient from SPAIN , 60 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Zofran (View Usage). Patient had the following side effects: neuroleptic malignant syndrome. Zofran dosage: 4mg Per Day. During the same period patient was treated with PRIMPERAN (View Primperan Review and Primperan Label ), FENTANEST (View Fentanest Review and Fentanest Label ), ETOMIDATE (View Etomidate Review and Etomidate Label ), PROPOFOL (View Propofol Review and Propofol Label ), ATROPINA (View Atropina Review and Atropina Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CLEXANE (20mg Per Day) (View Clexane Review and Clexane Label ), DEXAMETASONA (4mg Per Day) (View Dexametasona Review and Dexametasona Label ).

6379445-9 | Acidosis, Cardiac Arrest, Depressed Level Of Consciousness, Hyperthermia, Hyperthermia Malignant, Muscle Rigidity, Pneumonia, Pyrexia, Serotonin Syndrome
Patient was taking Zofran (View Usage). After Zofran was administered, patient had the following side effects: acidosis, cardiac arrest (What is cardiac arrest?), depressed level of consciousness, hyperthermia, hyperthermia malignant, muscle rigidity, pneumonia (What is pneumonia?), pyrexia, serotonin syndrome on Sep 23, 2009 from SPAIN Additional patient health information: Male patient , child 5 years of age, was diagnosed with vomiting and. Zofran dosage: .

6379397-1 | Lung Neoplasm Malignant, Pneumonia
Adverse event was reported on Sep 25, 2009 by a Male patient taking Zofran (View Usage) (Dosage: 2mg Every Two Weeks) was diagnosed with prophylaxis of nausea and vomiting and. Location: UNITED STATES , 47 years of age, Patient experienced the following unwanted or unexpected effects: lung neoplasm malignant, pneumonia (What is pneumonia?). During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), DEXAMETHASONE 4MG TAB (View Dexamethasone 4mg Tab Review and Dexamethasone 4mg Tab Label ), BENADRYL (View Benadryl Review and Benadryl Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ).

6370564-X | Cardiac Arrest, Hyperthermia, Hyperthermia Malignant, Muscle Rigidity, Pyrexia, Serotonin Syndrome, Ventricular Tachycardia
on Sep 18, 2009 Male patient from SPAIN , child 5 years of age, was diagnosed with vomiting and was treated with Zofran (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), hyperthermia, hyperthermia malignant, muscle rigidity, pyrexia, serotonin syndrome, ventricular tachycardia. Zofran dosage: .

6368471-1 | Abdominal Pain, Alanine Aminotransferase Increased, Anaemia, Antibody Test Positive, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Cardiomegaly
on Sep 15, 2009 Female patient from UNITED STATES , 60 years of age, was treated with Zofran (View Usage). After Zofran was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, anaemia, antibody test positive, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cardiomegaly. Zofran dosage: . During the same period patient was treated with SYNTHROID (75mcg Per Day) (View Synthroid Review and Synthroid Label ), HERBAL SUPPLEMENT (View Herbal Supplement Review and Herbal Supplement Label ). Patient was hospitalized.

6359807-6 | Disease Progression
Patient was taking Zofran (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression on Sep 14, 2009 from UNITED STATES Additional patient health information: Male patient , 56 years of age, was diagnosed with prophylaxis of nausea and vomiting and. Zofran dosage: .15mgk Three Times Per Day. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), COMBIVENT (View Combivent Review and Combivent Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ).

6359806-4 | Disease Progression
Adverse event was reported on Sep 14, 2009 by a Male patient taking Zofran (View Usage) (Dosage: .15mgk Three Times Per Day) was diagnosed with prophylaxis of nausea and vomiting and. Location: UNITED STATES , 47 years of age, Patient had the following side effects: disease progression. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), COMPAZINE (View Compazine Review and Compazine Label ). Patient was hospitalized.

6337814-7 |
on Aug 27, 2009 Male patient from UNITED STATES , 47 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Zofran (View Usage). . Zofran dosage: .15mgk Three Times Per Day. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), COMPAZINE (View Compazine Review and Compazine Label ). Patient was hospitalized.

6336469-5 |
on Aug 27, 2009 Male patient from UNITED STATES , 56 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Zofran (View Usage). . Zofran dosage: .15mgk Three Times Per Day. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), COMBIVENT (View Combivent Review and Combivent Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ).

6330064-X |
Patient was taking Zofran (View Usage). on Aug 26, 2009 from UNITED STATES Additional patient health information: Female patient , 75 years of age, weighting 200.0 lb, was diagnosed with nausea (What is nausea?), atrial fibrillation (What is atrial fibrillation?) and. Zofran dosage: . During the same period patient was treated with BETAPACE (View Betapace Review and Betapace Label ).